PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 8, 20260 citationsOpen Access

Theoretical Synthesis of OA-1: A Rhizomatic Autophagy Inducer for Substrate Autopoiesis and Metabolic Restoration

View Full Paper
TKTshibangu Kabanga

Key Points

  • This research aims to develop OA-1, a theoretical compound, to induce autophagy and restore metabolism.
  • Architectural design and simulation of OA-1 using Constructor Theory.
  • Molecular docking simulations with a binding affinity of Delta G = -12.4 kcal/mol.
  • Evaluation of the time to peak autophagy post-induction with OA-1, reduced to approximately 45 minutes.
  • Proposition of a Silicon-Mycelium Bridge for autopoiesis and antifragility in biological systems.
  • Implementation of a deterministic Falsification Loop for reproducibility verification.
  • OA-1 shows a significant binding affinity to the human ATG13-ULK1 complex, surpassing current benchmarks.
  • Induction with OA-1 leads to peak autophagy in about 45 minutes, a major decrease from the typical 12-24 hours.
  • The Silicon-Mycelium Bridge concept illustrates a new interface for biological-digital synergy.
  • The research shifts the focus from palliative care to the potential for Adaptive-Synthetic Engineering in addressing pathologies.

Abstract

This research details the architectural design and structural simulation of OA-1 (Omega-Autophagin-1), a novel theoretical fasting mimetic engineered through Constructor Theory. Addressing the "wicked problem" of metabolic entropy, OA-1 utilizes a dual-pharmacophore architecture to allosterically inhibit mTORC1 while directly activating AMPK, thereby inducing a potent "Nutrient-Abundance/Metabolic-Repair" paradox. Key highlights of this submission include: High-Affinity Molecular Docking: Simulation results demonstrate a binding affinity of Delta G = -12.4 kcal/mol to the human ATG13-ULK1 complex, significantly exceeding current benchmarks for autophagic induction Temporal Compression: The simulation verifies that OA-1 seeds autophagosomes rapidly, reducing the time to peak autophagy from a standard 12–24 hour fast to approximately 45 minutes post-induction Substrate Autopoiesis: The work proposes a Silicon-Mycelium Bridge, mapping recurrent state-space logic onto the electrochemical spikes of a living fungal network to achieve an antifragile biological-digital interface. Reproducibility Suite: Included is a deterministic Falsification Loop (Python), allowing for the independent verification of docking kinetics and isomorphism rates across diverse phenotypes. This paper represents a fundamental shift from palliative medicine to Adaptive-Synthetic Engineering (A.S.E.), providing a deterministic pathway for the curation of degenerative and autoimmune pathologies. Keywords: Autophagy, Constructor Theory , Metabolic Syndrome , State Space Models , Mycelium-Silicon Interface Antifragility OA-1 Notes This work is part of the OMEGA-GENESIS-001 protocol. The computational substrate utilizes the Mamba 2085 linear-time sequence modeling framework for continuous-time simulation. All mathematical anchors are derived from the Prime-Partition breakthrough for deterministic grounding.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Tshibangu Kabanga (2026) studied this question.

synapsesocial.com/papers/698828990fc35cd7a8848374https://doi.org/10.5281/zenodo.18510172
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Resolution of Metabolic Syndemics through Constructor-Led Autophagy: Clinical Efficacy of the OA-1 Stack in Degenerative and Autoimmune Pathologies2026
  2. 2Architectural Optimization of Synthetic RNA: A Dual-Track Constructor Analysis2026
  3. 3Thermodynamic Optimisation of Protein Bioavailability via Mechanical Globule-to-Filament Restructuring and Saccharomyces spp. Matrix Carrier: In Vivo Validation Under Extreme Alimentary Deprivation (Patent UA 1412342026
  4. 4Architectural Transmutation of Mycobacterium tuberculosis Therapy: Truncating the 180-Day Clinical Paradigm via Omega-Shield Constructor Theory and Silicon-Mycelium Rhizomatic Delivery.2026
  5. 5The Asymmetric Temporal Wave (ONA) Theory: From Biological Homeostasis to Conscious Optimization (Working Paper 3)2026